![John D. Benson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John D.
Benson is Senior Director of Biology for Mersana Therapeutics, Inc. Most recently, he served as Program Team Head and Sr. Research Investigator for Small Molecule Therapeutics in Oncology Drug Discovery at Novartis Institutes for Biomedical Research.
From 1999 to 2003, Dr. Benson served as Director of Molecular and Discovery Biology for Enanta Pharmaceuticals, Inc. He served as Team Head for the Novartis Oncology siRNA Therapeutics Program.
Dr. Benson was a Principal at Harvard Medical School and Damon-Runyon Walter Winchell Fellow at the National Cancer Institute.
He received his PhD degree in Genetics from the University of North Carolina at Chapel Hill.
| Unternehmen | Position | Ende |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
Biomedical Research Models, Inc.
 Biomedical Research Models, Inc. BiotechnologyHealth Technology Develops and utilizes specialty animal models to determine the efficacy of new drugs in preventing or ameliorating human diseases | Corporate Officer/Principal | - |
| ENANTA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
| MERSANA THERAPEUTICS | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Biomedical Research Models, Inc.
Biomedical Research Models, Inc. BiotechnologyHealth Technology Develops and utilizes specialty animal models to determine the efficacy of new drugs in preventing or ameliorating human diseases | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
